Concurrent Sessions C01 - C06 - Saturday, June 6 - 18.30 - 20.00 hrs

RoomClyde AuditoriumHall 5Hall 2Lomond AuditoriumHall 1Forth Room
C01. NIPTC02. Improvement in genome sequencing and functional studiesC03. Novel genes causing intellectual disabilityC04. The many faces of cancer mutationsC05. Cardiovascular disordersC06. Neuromuscular disorders
18.30

C01.1

Implementation of a non-invasive prenatal testing (NIPT) for aneuploidy service in an NHS diagnostic laboratory

Lyn S. Chitty, F.J. McKay, S. Mason, C. Boustred, K. Lo, L. Jenkins, R. Daley, M. Hill, C. Lewis, S. Drury, J. Fisher, T. Verhoef, S. Morris;
London, United Kingdom

C02.1

Single cell analysis “simplification” dramatically increases complexity: considerations in technique, quality control, analysis, and possibilities for translation to the clinic

Lisa D. White, J.D. Landua, L. Simon, M.T. Bernardi, D. Xavier, C.A. Shaw, M.T. Lewis;
Houston, United States

C03.1

De novo and familial DDX3X mutations are associated with X-linked intellectual disability and a diverse phenotypic spectrum

Lot Snijders Blok*, E. Madsen, M. Reijnders, H. Venselaar, C. Helsmoortel, C. Gillissen, A. Hoischen, L. Vissers, T. Koemans, W. Wissink, E.E. Eichler, C. Romano, H. Van Esch, C. Stumpel, M. Vreeburg, E. Smeets, B. van Bon, M. Shaw, J. Gecz, M. Bienek, C. Jensen, B. Loeys, A. van Dijck, A.M. Innes, N. Di Donato, S.G. Mehta, K. Tatton-Brown, D. Baralle, A. Henderson, S. Dijkstra, J. Schieving, S. Haas, H. Brunner, F. Kooy, C. van Roozendaal, R. Pfundt, V. Kalscheuer, N. Katsanis, T. Kleefstra;
Nijmegen, Netherlands

C04.1

Mosaic loss of chromosome Y (LOY) in peripheral blood is associated with smoking, shorter survival and increased risk of cancer

Lars A. Forsberg, C. Rasi, M. Lönn, H. Davies, M. Ingelsson, V. Giedraitis, L. Lannfelt, N.N.C. Cross, D. Absher, P.K.E. Magnusson, C. Lindgren, A.P. Morris, D. Cesarini, M. Johannesson, E. Tiensuu, L. Lind, N.L. Pedersen, E. Ingelsson, J. Dumanski;
Uppsala, Sweden

C05.1

MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of Familial Thoracic Aortic Aneurysms and Dissections

Mathieu Barbier, M. Gross, M. Aubart, N. Hanna, K. Kessler, D. Guo, L. Tosolini, B. Ho-Tin-Noe, E. Regalado, M. Varret, M. Abifadel, O. Milleron, S. Odent, S. Dupuis-Girod, L. Faivre, T. Edouard, Y. Dulac, T. Busa, L. Gouya, D. Milewicz, G. Jondeau, C. Boileau;
Paris, France

C06.1

Neurogenetic disease diagnostics by targeted capture and next generation sequencing

Nigel G. Laing, K. Yau, R. Allcock, R. Ong, K. Mina, G. Ravenscroft, M. Cabrera, R. Gooding, C. Wise, P. Sivadorai, D. Trajanoski, V. Atkinson, S. Wagner, K.J. Nowak, R.M. Duff, P.J. Lamont, M.R. Davis;
Nedlands, Australia

18.45

C01.2

TRIDENT: or monitored NIPT implementation in the Netherlands

Erik A. Sistermans, G.H. Schuring-Blom, B.H.W. Faas, E.M.J. Boon, C.J. Bax, A.B.C. Coumans, A.T.J.I. Go, K. Huijsdens-van Amsterdam, M.V.E. Macville, D. van Opstal, E. Pajkrt, B. Sikkema-Raddatz, R.F. Suijkerbuijk, J.M.G. van Vugt, M.M. Weiss, G.C.M.L. Page-Christiaens, D. Oepkes;
Amsterdam, Netherlands

C02.2

Large-scale genotyping of polymorphic inversions in the human genome

Sergi Villatoro*, R. Zaurin, M. Gayà-Vidal, C. Giner-Delgado, D. Vicente-Salvador, D. Izquierdo, M. Oliva, L. Pantano, M. Puig, M. Cáceres;
Bellaterra (Barcelona), Spain

C03.2

De novo and recurrent PPP2R5D and PPP2R1A missense mutations cause protein phosphatase 2A dysfunction and intellectual disability

Dorien Haesen*, V. Janssens, L.E.L.M. Vissers, S. Mehta, M.J. Parker, M. Wright, J. Vogt, S. McKee, J.L. Tolmie, N. Cordeiro, T. Kleefstra, M.H. Willemsen, M.R.F. Reijnders, S. Berland, E. Hayman, E. Lahat, E.H. Brilstra, K.L.I. van Gassen, E. Zonneveld-Huijssoon, C.I. de Bie, A. Hoischen, E.E. Eichler, R. Holdhus, V.M. Steen, S.O. Døskeland, M.E. Hurles, D.R. FitzPatrick, T. DDD-study, G. Houge;
Leuven, Belgium

C04.2

SNP-SNP interaction analysis of NF-kB signaling pathway on breast cancer survival

Maral Jamshidi*, R. Fagerholm, S. Khan, K. Aittomäki, D.E. Easton, P. Hall, C. Blomqvist, M.K. Schmidt, H. Nevanlinna, B. C.A.C (Breast Cancer Association Consortium);
Helsinki, Finland

C05.2

Mutations in a TGF? ligand, TGFB3, cause syndromic aortic aneurysms and dissections

Elisabeth Gillis*, A.M. Bertoli-Avella, H. Morisaki, J.M.A. Verhagen, E. Gallo, B.P.T. Kruithof, S. Laga, A.J. Doyle, G. Oswald, M. Lammens, C. Evers, K. Devriendt, M. Dumoulein, J. Timmermans, I. Rodrigus, G. Baynam, M. Kempers, J. Saenen, E.M. Van Craenenbroeck, K. Minatoya, R. Matsukawa, T. Tsukube, N. Kubo, M. Goumans, J.W. Roos-Hesselink, I.M.B.H. van de Laar, H.C. Dietz, L. Van Laer, T. Morisaki, M.W. Wessels, B.L. Loeys;
Antwerp, Belgium

C06.2

The SMCHD1 mutation spectrum in Facioscapulohumeral muscular dystrophy

Marlinde L. van den Boogaard*, R.J.L.F. Lemmers, P.J. van der Vliet, J. Balog, B. Bakker, S.J. Tapscott, S. Sacconi, R. Tawil, S.M. van der Maarel;
Leiden, Netherlands

19.00

C01.3

Non-invasive prenatal diagnosis; expansion from de novo to autosomal recessive disorders using congenital adrenal hyperplasia as an example

Suzanne Drury, K. Lo, C. Boustred, F. McKay, S. Mason, P. Twiss, S. Edwards, M. Hill, C. Lewis, R. Daley, L. Jenkins, L. Chitty;
London, United Kingdom

C02.3

Large-scale single-molecule sequencing of tandem repeats on the human X chromosome

Alena Zablotskaya*, G. Peeters, W.I.M. Meert, K.J. Verstrepen, G. Froyen, J.R. Vermeesch;
Leuven, Belgium

C03.3

Mutations in genes encoding components of protein phosphatase 2A (PP2A) cause human overgrowth and intellectual disability

Chey Loveday, K. Tatton-Brown, M. Clarke, I. Westwood, A. Renwick, E. Ruark, E. Ramsay, R. van Montfort, N. Rahman;
London, United Kingdom

C04.3

Towards understanding the genomic architecture of cancer genomes

Ernest T. Lam*, A.R. Hastie, M.B. Imielinski, C. Zhang, J. Wala, Z. Dzakula, H. Cao;
San Diego, United States

C05.3

Exome-chip meta-analysis identifies novel associations of coding variants with cardiac conduction in 62,251 adults of European descent from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.

Yalda Jamshidi, B.P. Prins, C. Liu, J. van Setten, L. Hall, F. Radmanesh, CHARGE Consortium Exome-Chip EKG Working Group;
London, United Kingdom

C06.3

Plastin 3, a human protective modifier is highly upregulated in iPSC-derived motoneurons in asymptomatic individuals and rescues spinal muscular atrophy in mice

M. Peters, L. Heesen, S. Hosseini Barkooie, M. Peitz, A. Kaczmarek, E. Janzen, O. Brüstle, Brunhilde Wirth;
Cologne, Germany

19.15

C01.4

Non-invasive prenatal diagnosis (NIPD) of Duchenne and Becker muscular dystrophies (DMD/BMD) by relative haplotype dosage

Michael Parks*, S. Court, S. Cleary, S. Clokie, J. Hewitt, D. Williams, T. Cole, F. MacDonald, M. Griffiths, S.K. Allen;
Birmingham, United Kingdom

C02.4

The value of long-read single molecule sequencing in diagnostics

S.Y. Anvar, H. Buermans, R. Vossen, M. Liem, Monique Losekoot, T. van der Straaten, H. van der Klift, J. Wijnen, J. Swen, D. Peters, J. T. den Dunnen;
Leiden, Netherlands

C03.4

De novo mutations in BCL11A cause developmental delay: additional implications of the BAF SWI/SNF complex in intellectual disability and autism

Cristina Dias*, J.A. Hurst, S. Joss, S.E. Holder, G. Sánchez-Andrade, S.J. Sawiak, S. Lee, P. Liu, M.E. Hurles, D.D.D. Deciphering Developmental Disorders Study, D.W. Logan;
Hinxton, Cambridge, United Kingdom

C04.4

Molecular classification of diffuse cerebral gliomas using genome- and transcriptomewide profiling.

M. Weller, R.G. Weber, E. Willscher, V. Riehmer, B. Hentschel, M. Kreuz, J. Felsberg, Ulrike Beyer, H. Wirth, K. Kaulich, J. Steinbach, C. Hartmann, D. Gramatzki, J. Schramm, M. Westphal, G. Schackert, M. Simon, T. Martens, J. Boström, C. Hagel, M. Sabel, D. Krex, J.C. Tonn, W. Wick, S. Noell, U. Schlegel, B. Radlwimmer, T. Pietsch, M. Loeffler, A. von Deimling, H. Binder, G. Reifenberger, German Glioma Network;
Hannover, Germany

C05.4

A genome-wide association study of nonsyndromic mitral valve prolapse and functional studies of risk loci provide insight into underlying biological mechanisms

Nabila Bouatia-Naji, C. Dina, N. Tucker, R.A. Norris, D. Milan, S. Slaugenhaupt, R.A. Levine, J. Schott, A.A. Hagège, X. Jeunemaitre;
Paris, France

C06.4

Analysis of the Gdap1 knockout mice reveals calcium homeostasis and mitochondrial dynamics defects in the Charcot-Marie-Tooth disease pathogenesis

Azahara Civera-Tregón*, P. Juárez, M. Barneo-Muñoz, S. Fernández-Lizarbe, D. Pla-Martin, J. Zenker, C. Cuevas-Martín, M. Sánchez-Aragó, J. Forteza-Vila, J.M. Cuezva, R. Chrast, F. Palau;
Valencia, Spain

19.30

C01.5

Incidental findings of genome wide non-invasive fetal aneuploidy detection (NIPT): presymptomatic identification of maternal cancers

Nathalie Brison*, K. Van Den Bogaert, P. Brady, L. Dehaspe, I. Wlodarska, F. Amant, P. Vandenberghe, T. de Ravel, H. Peeters, H. Van Esch, K. Devriendt, E. Legius, J.R. Vermeesch;
Leuven, Belgium

C02.5

Comparison of exome and genome sequencing technologies for the complete capture of protein coding regions

Stefan H. Lelieveld*, M. Spielmann, S. Mundlos, J.A. Veltman, C. Gilissen;
Nijmegen, Netherlands

C03.5

De novo loss-of-function mutations in WAC in the 10p12p11 critical region cause intellectual disability

Margot R.F. Reijnders*, D. Lugtenberg, M. Fenckova, E.K. Bijlsma, B.W.M. van Bon, A.T. Vulto- van Silfhout, D.G.M. Bosch, E.E. Eichler, H.C. Mefford, R. Pfundt, H.G. Yntema, P.F. de Vries, J.A. Veltman, B.B.A. de Vries, A. Hoichen, A. Schenck, T. Kleefstra, L.E.L.M. Vissers;
Nijmegen, Netherlands

C04.5

Vaccination with monocyte-derived dendritic cells in Lynch syndrome patients: vigorous T cell responses to neoantigen frameshift-derived peptides.

Nicoline Hoogerbrugge, H. Westdorp, G. Schreibelt, K. Bol, M. Welzen, J. Krieken, T. Bisseling, M. Ligtenberg, W. Gerritsen, C. Figdor, I. Vries;
Nijmegen, Netherlands

C05.5

Recessive mutations in matrix metallopeptidase 21 (MMP21) cause heterotaxy in humans

Anne Guimier*, G. Gabriel, F. Bajolle, M. Tsang, M. Schwartz, A. Noll, L. Smith, H. Yagi, C. Saunders, C. Baker, M. Oufadem, N. Miller, K. Peterson, I. Thiffault, N. Klena, C. Bole-Feysot, P. Nitschke, S. Lyonnet, L. de Pontual, S. Murray, D. Bonnet, S. Kingsmore, J. Amiel, P. Bouvagnet, C. Lo, C. Gordon;
Paris, France

C06.5

Junctophilin-1 expression levels could modify the effects of GDAP1 mutations in Charcot-Marie-Tooth disease

Eduardo Calpena*, V. Lupo, T. Sevilla, F. Palau, I. Galindo, C. Espinós;
Valencia, Spain

19.45

C01.6

Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening - an ESHG/ASHG position statement

Wybo Dondorp, G. de Wert, C.G. Van El, M.C. Cornel;
Maastricht, Netherlands

C02.6

A significant proportion of de novo point mutations arise post-zygotically

R. Acuna-Hidalgo, T. Bo, M. Kwint, M. van de Vorst, M. Pinelli, J.A. Veltman, H. Alexander, L.E.L.M. Vissers, Christian Gilissen;
Nijmegen, Netherlands

C03.6

A novel syndrome of learning disability and obesity caused by 6q16 deletions encompassing the essential neurogenesis factor POU3F2 (Brn2) helps to delineate the neuro-endocrine pathway for body-mass control

Siddharth Banka, P. Kasher, K.E. Schertz, M. Thomas, S. Annunziata, M. Ballesta, P. Campeau, J.L. Eaton, T. Granata, E. Guillén-Navarro, A. Jackson, C.E. Laverriere, A. Liedén, O.V. Marcos, A. Nordgren, C. Pantaleoni, C. Pebrel-Richard, F.L. Sciacca, C. Sarret, R. Wright, B. Kerr, E. Glasgow;
Manchester, United Kingdom

C04.6

Through the looking glass: the reversion of EMT

Patricia Oliveira*, J. Carvalho, S. Rocha, M. Azevedo, A. Vieira, D. Ferreira, N. Mendes, I. Reis, J. Vinagre, A. Heravi-Moussavi, J. Nunes, J. Lima, V. Maximo, A. Burleigh, C. Roskelley, F. Carneiro, R. Seruca, J. Paredes, D. Huntsman, C. Oliveira;
Porto, Portugal

C05.6

Somatic/mosaic mutations are an important cause of sporadic vascular anomalies.

Miikka Vikkula, A. Mendola, J. Soblet, M. Schlögel, M. Amyere, P. Brouillard, N. Limaye, L.M. Boon;
Brussels, Belgium

C06.6

CCDC174 mutation underlies a syndrome of hypotonia and psychomotor developmental delay with abducens nerve palsy

Michael Volodarsky*, H. Lichtig, T. Leibson, Y. Sadaka, K. Leibson, L. Gradstein, Z. Shorer, R. Shaco-Levy, D. Frank, O.S. Birk;
Beer-Sheva, Israel

City & Country refer to presenting authors
* indicates Young Investigator Award Candidates